aluates Reports

$ 0.0

Automative

Global Invasive Fungal Disease (IFD) Drugs Market Research Report 2026

Published Date: 2026-03-25

Report Code: QYRE-Auto-7V17426

Global Invasive Fungal Disease IFD Drugs Market Research Report 2024

BUY CHAPTERS

Global Invasive Fungal Disease (IFD) Drugs Market Research Report 2026

Code: QYRE-Auto-7V17426

Report

2026-03-25

Pages:105

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pfizer Inc

Merck

Gilead Sciences

Xellia

Lupin Ltd

Abbott

Creogenic Pharma

Taj Pharmaceuticals

Astellas Pharma

Jiangsu Aosaikang Pharmaceutical

Invasive Fungal Disease (IFD) Drugs Market Size

The global Invasive Fungal Disease (IFD) Drugs market was valued at US$ 2806 million in 2025 and is anticipated to reach US$ 3728 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

Invasive Fungal Disease (IFD) Drugs Market

Invasive Fungal Disease (IFD) refers to an infectious disease in which fungi invade the human body, grow and multiply in tissues, organs or blood, and cause inflammatory reactions and tissue damage. The main pathogenic bacteria are Aspergillus and Candida.The mainstream treatment methods for IFD are drug treatment and prevention. The mainstream drugs are triazole drugs, including posaconazole, itraconazole, fluconazole and voriconazole.

The North American market for Invasive Fungal Disease (IFD) Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Invasive Fungal Disease (IFD) Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Invasive Fungal Disease (IFD) Drugs in Hospital is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Invasive Fungal Disease (IFD) Drugs include Pfizer, Merck, Gilead Sciences, Xellia, Lupin Limited, Abbott, Creogenic Pharma, Taj Pharmaceuticals, Astellas Pharma, Jiangsu Aosaikang Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Invasive Fungal Disease (IFD) Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Invasive Fungal Disease (IFD) Drugs. The Invasive Fungal Disease (IFD) Drugs market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Invasive Fungal Disease (IFD) Drugs market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Invasive Fungal Disease (IFD) Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Invasive Fungal Disease (IFD) Drugs Market Report

Report Metric	Details
Report Name	Invasive Fungal Disease (IFD) Drugs Market
Accounted market size in 2025	US$ 2806 million
Forecasted market size in 2032	US$ 3728 million
CAGR	4.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Oral Medicine Injectable Medicine
Segment by Application	Hospital Drugstore Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Merck, Gilead Sciences, Xellia, Lupin Limited, Abbott, Creogenic Pharma, Taj Pharmaceuticals, Astellas Pharma, Jiangsu Aosaikang Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Invasive Fungal Disease (IFD) Drugs companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Invasive Fungal Disease (IFD) Drugs Market growing?

Ans: The Invasive Fungal Disease (IFD) Drugs Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the Invasive Fungal Disease (IFD) Drugs Market size in 2032?

Ans: The Invasive Fungal Disease (IFD) Drugs Market size in 2032 will be US$ 3728 million.

Who are the main players in the Invasive Fungal Disease (IFD) Drugs Market report?

Ans: The main players in the Invasive Fungal Disease (IFD) Drugs Market are Pfizer, Merck, Gilead Sciences, Xellia, Lupin Limited, Abbott, Creogenic Pharma, Taj Pharmaceuticals, Astellas Pharma, Jiangsu Aosaikang Pharmaceutical

What are the Application segmentation covered in the Invasive Fungal Disease (IFD) Drugs Market report?

Ans: The Applications covered in the Invasive Fungal Disease (IFD) Drugs Market report are Hospital, Drugstore, Clinic, Others

What are the Type segmentation covered in the Invasive Fungal Disease (IFD) Drugs Market report?

Ans: The Types covered in the Invasive Fungal Disease (IFD) Drugs Market report are Oral Medicine, Injectable Medicine

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Oral Medicine

1.2.3 Injectable Medicine

1.3 Market by Application

1.3.1 Global Invasive Fungal Disease (IFD) Drugs Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Hospital

1.3.3 Drugstore

1.3.4 Clinic

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Invasive Fungal Disease (IFD) Drugs Market Perspective (2021–2032)

2.2 Global Invasive Fungal Disease (IFD) Drugs Growth Trends by Region

2.2.1 Global Invasive Fungal Disease (IFD) Drugs Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Invasive Fungal Disease (IFD) Drugs Historic Market Size by Region (2021–2026)

2.2.3 Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Region (2027–2032)

2.3 Invasive Fungal Disease (IFD) Drugs Market Dynamics

2.3.1 Invasive Fungal Disease (IFD) Drugs Industry Trends

2.3.2 Invasive Fungal Disease (IFD) Drugs Market Drivers

2.3.3 Invasive Fungal Disease (IFD) Drugs Market Challenges

2.3.4 Invasive Fungal Disease (IFD) Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Invasive Fungal Disease (IFD) Drugs Players by Revenue

3.1.1 Global Top Invasive Fungal Disease (IFD) Drugs Players by Revenue (2021–2026)

3.1.2 Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Players (2021–2026)

3.2 Global Top Invasive Fungal Disease (IFD) Drugs Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Invasive Fungal Disease (IFD) Drugs Revenue

3.4 Global Invasive Fungal Disease (IFD) Drugs Market Concentration Ratio

3.4.1 Global Invasive Fungal Disease (IFD) Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Invasive Fungal Disease (IFD) Drugs Revenue in 2025

3.5 Global Key Players of Invasive Fungal Disease (IFD) Drugs Head Offices and Areas Served

3.6 Global Key Players of Invasive Fungal Disease (IFD) Drugs, Products and Applications

3.7 Global Key Players of Invasive Fungal Disease (IFD) Drugs, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Invasive Fungal Disease (IFD) Drugs Breakdown Data by Type

4.1 Global Invasive Fungal Disease (IFD) Drugs Historic Market Size by Type (2021–2026)

4.2 Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Type (2027–2032)

5 Invasive Fungal Disease (IFD) Drugs Breakdown Data by Application

5.1 Global Invasive Fungal Disease (IFD) Drugs Historic Market Size by Application (2021–2026)

5.2 Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)

6.2 North America Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)

6.4 North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)

7.2 Europe Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)

7.4 Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)

8.2 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (2021–2026)

8.4 Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)

9.2 Latin America Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)

9.4 Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size (2021–2032)

10.2 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (2021–2026)

10.4 Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Invasive Fungal Disease (IFD) Drugs Introduction

11.1.4 Pfizer Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

11.1.5 Pfizer Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Invasive Fungal Disease (IFD) Drugs Introduction

11.2.4 Merck Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

11.2.5 Merck Recent Development

11.3 Gilead Sciences

11.3.1 Gilead Sciences Company Details

11.3.2 Gilead Sciences Business Overview

11.3.3 Gilead Sciences Invasive Fungal Disease (IFD) Drugs Introduction

11.3.4 Gilead Sciences Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

11.3.5 Gilead Sciences Recent Development

11.4 Xellia

11.4.1 Xellia Company Details

11.4.2 Xellia Business Overview

11.4.3 Xellia Invasive Fungal Disease (IFD) Drugs Introduction

11.4.4 Xellia Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

11.4.5 Xellia Recent Development

11.5 Lupin Limited

11.5.1 Lupin Limited Company Details

11.5.2 Lupin Limited Business Overview

11.5.3 Lupin Limited Invasive Fungal Disease (IFD) Drugs Introduction

11.5.4 Lupin Limited Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

11.5.5 Lupin Limited Recent Development

11.6 Abbott

11.6.1 Abbott Company Details

11.6.2 Abbott Business Overview

11.6.3 Abbott Invasive Fungal Disease (IFD) Drugs Introduction

11.6.4 Abbott Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

11.6.5 Abbott Recent Development

11.7 Creogenic Pharma

11.7.1 Creogenic Pharma Company Details

11.7.2 Creogenic Pharma Business Overview

11.7.3 Creogenic Pharma Invasive Fungal Disease (IFD) Drugs Introduction

11.7.4 Creogenic Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

11.7.5 Creogenic Pharma Recent Development

11.8 Taj Pharmaceuticals

11.8.1 Taj Pharmaceuticals Company Details

11.8.2 Taj Pharmaceuticals Business Overview

11.8.3 Taj Pharmaceuticals Invasive Fungal Disease (IFD) Drugs Introduction

11.8.4 Taj Pharmaceuticals Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

11.8.5 Taj Pharmaceuticals Recent Development

11.9 Astellas Pharma

11.9.1 Astellas Pharma Company Details

11.9.2 Astellas Pharma Business Overview

11.9.3 Astellas Pharma Invasive Fungal Disease (IFD) Drugs Introduction

11.9.4 Astellas Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

11.9.5 Astellas Pharma Recent Development

11.10 Jiangsu Aosaikang Pharmaceutical

11.10.1 Jiangsu Aosaikang Pharmaceutical Company Details

11.10.2 Jiangsu Aosaikang Pharmaceutical Business Overview

11.10.3 Jiangsu Aosaikang Pharmaceutical Invasive Fungal Disease (IFD) Drugs Introduction

11.10.4 Jiangsu Aosaikang Pharmaceutical Revenue in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

11.10.5 Jiangsu Aosaikang Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Pfizer Inc

Merck

Gilead Sciences

Xellia

Lupin Ltd

Abbott

Creogenic Pharma

Taj Pharmaceuticals

Astellas Pharma

Jiangsu Aosaikang Pharmaceutical

List of Tables

Table 1. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Oral Medicine

Table 3. Key Players of Injectable Medicine

Table 4. Global Invasive Fungal Disease (IFD) Drugs Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million), 2021–2026

Table 7. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region (2021–2026)

Table 8. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region (2027–2032)

Table 10. Invasive Fungal Disease (IFD) Drugs Market Trends

Table 11. Invasive Fungal Disease (IFD) Drugs Market Drivers

Table 12. Invasive Fungal Disease (IFD) Drugs Market Challenges

Table 13. Invasive Fungal Disease (IFD) Drugs Market Restraints

Table 14. Global Invasive Fungal Disease (IFD) Drugs Revenue by Players (US$ Million), 2021–2026

Table 15. Global Invasive Fungal Disease (IFD) Drugs Market Share by Players (2021–2026)

Table 16. Global Top Invasive Fungal Disease (IFD) Drugs Players by Tier (Tier 1, Tier 2, and Tier 3), based on Invasive Fungal Disease (IFD) Drugs Revenue, 2025

Table 17. Ranking of Global Top Invasive Fungal Disease (IFD) Drugs Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Invasive Fungal Disease (IFD) Drugs Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Headquarters and Area Served

Table 20. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Products and Applications

Table 21. Global Key Players of Invasive Fungal Disease (IFD) Drugs, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Invasive Fungal Disease (IFD) Drugs Market Size by Type (US$ Million), 2021–2026

Table 24. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Type (2021–2026)

Table 25. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Type (2027–2032)

Table 27. Global Invasive Fungal Disease (IFD) Drugs Market Size by Application (US$ Million), 2021–2026

Table 28. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Application (2021–2026)

Table 29. Global Invasive Fungal Disease (IFD) Drugs Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Invasive Fungal Disease (IFD) Drugs Revenue Market Share by Application (2027–2032)

Table 31. North America Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026

Table 33. North America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size by Country (US$ Million), 2027–2032

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer Invasive Fungal Disease (IFD) Drugs Product

Table 49. Pfizer Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026

Table 50. Pfizer Recent Development

Table 51. Merck Company Details

Table 52. Merck Business Overview

Table 53. Merck Invasive Fungal Disease (IFD) Drugs Product

Table 54. Merck Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026

Table 55. Merck Recent Development

Table 56. Gilead Sciences Company Details

Table 57. Gilead Sciences Business Overview

Table 58. Gilead Sciences Invasive Fungal Disease (IFD) Drugs Product

Table 59. Gilead Sciences Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026

Table 60. Gilead Sciences Recent Development

Table 61. Xellia Company Details

Table 62. Xellia Business Overview

Table 63. Xellia Invasive Fungal Disease (IFD) Drugs Product

Table 64. Xellia Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026

Table 65. Xellia Recent Development

Table 66. Lupin Limited Company Details

Table 67. Lupin Limited Business Overview

Table 68. Lupin Limited Invasive Fungal Disease (IFD) Drugs Product

Table 69. Lupin Limited Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026

Table 70. Lupin Limited Recent Development

Table 71. Abbott Company Details

Table 72. Abbott Business Overview

Table 73. Abbott Invasive Fungal Disease (IFD) Drugs Product

Table 74. Abbott Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026

Table 75. Abbott Recent Development

Table 76. Creogenic Pharma Company Details

Table 77. Creogenic Pharma Business Overview

Table 78. Creogenic Pharma Invasive Fungal Disease (IFD) Drugs Product

Table 79. Creogenic Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026

Table 80. Creogenic Pharma Recent Development

Table 81. Taj Pharmaceuticals Company Details

Table 82. Taj Pharmaceuticals Business Overview

Table 83. Taj Pharmaceuticals Invasive Fungal Disease (IFD) Drugs Product

Table 84. Taj Pharmaceuticals Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026

Table 85. Taj Pharmaceuticals Recent Development

Table 86. Astellas Pharma Company Details

Table 87. Astellas Pharma Business Overview

Table 88. Astellas Pharma Invasive Fungal Disease (IFD) Drugs Product

Table 89. Astellas Pharma Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026

Table 90. Astellas Pharma Recent Development

Table 91. Jiangsu Aosaikang Pharmaceutical Company Details

Table 92. Jiangsu Aosaikang Pharmaceutical Business Overview

Table 93. Jiangsu Aosaikang Pharmaceutical Invasive Fungal Disease (IFD) Drugs Product

Table 94. Jiangsu Aosaikang Pharmaceutical Revenue in Invasive Fungal Disease (IFD) Drugs Business (US$ Million), 2021–2026

Table 95. Jiangsu Aosaikang Pharmaceutical Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Invasive Fungal Disease (IFD) Drugs Picture

Figure 2. Global Invasive Fungal Disease (IFD) Drugs Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Invasive Fungal Disease (IFD) Drugs Market Share by Type: 2025 vs 2032

Figure 4. Oral Medicine Features

Figure 5. Injectable Medicine Features

Figure 6. Global Invasive Fungal Disease (IFD) Drugs Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Invasive Fungal Disease (IFD) Drugs Market Share by Application: 2025 vs 2032

Figure 8. Hospital Case Studies

Figure 9. Drugstore Case Studies

Figure 10. Clinic Case Studies

Figure 11. Others Case Studies

Figure 12. Invasive Fungal Disease (IFD) Drugs Report Years Considered

Figure 13. Global Invasive Fungal Disease (IFD) Drugs Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 14. Global Invasive Fungal Disease (IFD) Drugs Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 15. Global Invasive Fungal Disease (IFD) Drugs Market Share by Region: 2025 vs 2032

Figure 16. Global Invasive Fungal Disease (IFD) Drugs Market Share by Players in 2025

Figure 17. Global Invasive Fungal Disease (IFD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 18. The Top 10 and 5 Players Market Share by Invasive Fungal Disease (IFD) Drugs Revenue in 2025

Figure 19. North America Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 20. North America Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)

Figure 21. United States Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Canada Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 24. Europe Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)

Figure 25. Germany Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. France Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. U.K. Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Italy Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Russia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Ireland Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Asia-Pacific Invasive Fungal Disease (IFD) Drugs Market Share by Region (2021–2032)

Figure 33. China Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Japan Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. South Korea Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Southeast Asia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. India Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Australia & New Zealand Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Latin America Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)

Figure 41. Mexico Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Brazil Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Middle East & Africa Invasive Fungal Disease (IFD) Drugs Market Share by Country (2021–2032)

Figure 45. Israel Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Saudi Arabia Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. UAE Invasive Fungal Disease (IFD) Drugs Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Pfizer Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

Figure 49. Merck Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

Figure 50. Gilead Sciences Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

Figure 51. Xellia Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

Figure 52. Lupin Limited Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

Figure 53. Abbott Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

Figure 54. Creogenic Pharma Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

Figure 55. Taj Pharmaceuticals Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

Figure 56. Astellas Pharma Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

Figure 57. Jiangsu Aosaikang Pharmaceutical Revenue Growth Rate in Invasive Fungal Disease (IFD) Drugs Business (2021–2026)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Invasive Fungal Infection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti invasive Fungal Infection IFI Drug Market Research Report 2024

Global Fungal 1 3 β D Glucan Detection Kit Market Research Report 2024

Global Fungal Infection Diagnosis Market Insights Forecast to 2030

Global Fungal Infection Rapid Diagnosis Kit Market Research Report 2024

Global Voriconazole Vfend Market Research Report 2024

Global Fungal Infection Diagnostic Kit Market Research Report 2024

Global Fluconazole Preparation Market Research Report 2024

Systemic Antifungals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Immunological Testing for Invasive Fungal Infections Market Research Report 2024

Global Antifungal Drugs for Skin Market Research Report 2024

Global Mucormycosis Treatment Drugs Market Research Report 2025

Global Antifungal and Ringworm Treatment Drugs Market Research Report 2025

Antifungal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Azole Antifungals Market Research Report 2024

Global Fenticonazole Market Research Report 2024

Global Anti fungal Drugs Market Insights Forecast to 2030

Global Isavuconazole Sulfate for Injection Market Research Report 2024

Global Posaconazole Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions